Wellorithm Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.9/10
Best for: compounded semaglutide at $247/month
Wellorithm falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $247/mo ongoing
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked July 2026
Louisiana is the single state Wellorithm does not reach; the other 49 it does. Compounded semaglutide and compounded tirzepatide come as injectables or as oral dissolving tablets. Board-certified obesity specialists run the virtual consultations, with support on hand 24/7. This GLP-1 telehealth operation is based in Miami.
Is Wellorithm legit?
Yes. Wellorithm is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 5.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Wellorithm promo or coupon code?
Wellorithm has no coupon code to enter. New patients are currently quoted $147 for the first month, then $247 a month, and the discount applies on its own. Coupon sites advertising a "Wellorithm promo code" are not a source we can vouch for.
See how Wellorithm compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Wellorithm at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $247/mo
- Availability
- 49 states
- FDA status
- No FDA warning letters found
How Wellorithm scores
Six columns, each one computed from something Wellorithm has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
2.9/10$247/month is 34% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
9.8/10Serves 49 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Wellorithm
Last checked July 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked FDA warning letters for Wellorithm
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Wellorithm involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Wellorithm shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Wellorithm which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $247, tirzepatide $349. That leaves out membership fees, first-month rates and insurance copays.
- Wellorithm serves 49 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Wellorithm
- Phone
- +1 (877) 402-6778
- Wellorithm offers email support
- Hours
- 24/7
GLP-1 medications Wellorithm offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Shown only at Wellorithm's checkout, not its marketing pages: $247/mo ongoing, '$100 off your first month' ($147), or a 3-month bundle for $645 ($215/mo).
At Wellorithm's checkout: $349/mo ongoing, $249 for the first month ($100 off), or a 3-month bundle for $947 (~$316/mo).
Check the price yourself before you pay
Every figure here was read off Wellorithm's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Serves 49 states
- We found no FDA warning letters issued to Wellorithm
Against it
- Semaglutide costs $247 a month, 34% above the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 40% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Wellorithm charges
Wellorithm advertises $147. That buys the first month. The standing rate is $247/month, and that is the one worth doing the math on, because the introductory figure applies once.
- Compounded semaglutide: $147 first month, then $247/month
- Compounded tirzepatide: $249 first month, then $349/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so Wellorithm's $247 is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much.
Eden dispenses semaglutide and tirzepatide from $239/month, which makes it the fair comparison to run before you commit here.
What Wellorithm dispenses
Wellorithm prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Wellorithm at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Wellorithm tells you that it treats patients in all 50 states. We found no FDA warning letters issued to Wellorithm. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Wellorithm will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Wellorithm bills your plan before you start.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
- injections are the thing keeping you from starting
- you need access wherever you live
Our read
Wellorithm is a cheap way to start and an ordinary way to continue. Use the $147 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $247/month before you let it renew twice. The catch is disclosure, which is why Wellorithm scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Direct Meds is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Wellorithm falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay Wellorithm
Starting at $147 a month. Check today's price, then start the intake.
Where Wellorithm is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider Oak.
Alternatives to Wellorithm
Editorial score · methodology
Editorial score · methodology
Bodybuilding Health+
Best for: seeing what it charges before you answer any medical questions
Editorial score · methodology
Compare Wellorithm head to head
The sellers closest to Wellorithm on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Wellorithm review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of July 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Wellorithm's current pricing
Plans start at $147 a month. Whether you qualify is a clinician's decision, made after your intake.